| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 3,082,268 | 4,443,076 | ||
| Prepaid expenses and other current assets | 169,421 | 305,478 | ||
| Deferred offering costs | 101,170 | - | ||
| Total current assets | 3,352,859 | 4,748,554 | ||
| Property and equipment, net | 1,393,989 | 1,476,857 | ||
| Operating lease right-of-use assets | 134,683 | 155,683 | ||
| Other non-current assets | 8,727 | 22,164 | ||
| Total assets | 4,890,258 | 6,403,258 | ||
| Accounts payable | 161,162 | 108,817 | ||
| Operating lease liability, current | 100,002 | 100,002 | ||
| Accrued expenses and other current liabilities | 887,749 | 832,244 | ||
| Total current liabilities | 1,148,913 | 1,041,063 | ||
| Operating lease liability, non-current | 42,990 | 65,375 | ||
| Other non-current liabilities | 5,573 | 6,589 | ||
| Total liabilities | 1,197,476 | 1,113,027 | ||
| Common stock, 0.0001 par value 250,000,000 shares authorized 1,639,133 and 554,012 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 164 | 149 | ||
| Additional paid-in capital | 43,780,073 | 43,779,905 | ||
| Accumulated deficit | -40,087,455 | -38,489,823 | ||
| Total stockholders equity | 3,692,782 | 5,290,231 | ||
| Total liabilities and stockholders equity | 4,890,258 | 6,403,258 | ||
Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc. (BJDX)